Cell-based constructs and biomaterial formulations have enormous potential for innovation for the next generation of clinically relevant engineered tissues. Given the complex architecture and heterogeneous composition of native tissue, 3D printing and bioprinting techniques provide a significant advantage towards recapitulating this complexity. Such 3D printed in vitro tissues also serve as a useful bioengineered platform to better understand cell biology and mechanics that govern the functioning of the larger constructs.
The Research structure of CECT consists of three Technology Research and Development (TR&D) sites that interface with various academic and industrial partners on Collaborative (CP) and Service (SP) Projects. CECT is interested in developing novel printing technologies as well as 3D printed constructs for a variety of biological tissues including but not limited to bone, osteochondral interfaces, cartilage, heart, liver, skin, etc. Fundamental research carried out at each TR&D site, in partnership with the CPs and SPs help further the scientific and technological capabilities of the center. Enabling technologies, such as perfusable bioreactors and novel biomaterials help translate this research into clinical applications.
The Center structure consists of 3 core technology platforms (TR&Ds) that collaborate synergistically with other institutions on collaborative or service projects. CECT also contributes to the biomedical community through various workshops, training programs, and dissemination of technical knowledge garnered through the collaborations. The overarching goal is to address pressing issues in the clinical space.
By establishing new CPs and SPs, the center is always open to exploring new avenues of research and broadening its scientific capabilities. Details about the TR&Ds, active collaborations, and service projects can be found within their respective links.
Images courtesy of UMD.
Top